Afuco™ Anti-Human CLDN6 ADCC Recombinant Antibody (IMAB 027), ADCC Enhanced

CAT#: AFC-160CL

Anti-CLDN6 ADCC Enhanced Antibody (IMAB 027) is an ADCC enhanced antibody produced by our Afuco™ platform. IMAB027 is a first-in-class monoclonal antibody selectively binding to the cell surface protein Claudin-6 (CLDN6) which is present in a wide range of cancers, including testicular, ovarian, uterine, and lung cancers. A key advantage of IMAB027 is that CLDN6 is an embryonic antigen which is absent from healthy adult tissue. This unmatched tumor cell specificity of CLDN6 makes IMAB027 a cancer cell selective drug allowing it to efficiently kill tumor cells without harming healthy non-cancerous cells.

Gene Expression
Figure 1 RNA cell line category: Group enriched (BEWO, CACO-2, NTERA-2, SuSa)

Specifications

  • Host Species
  • Chimeric
  • Derivation
  • Chimeric
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Ovarian Cancer

Product Property

  • Purity
  • >98% by SDS-PAGE and HPLC analysis
  • Storage
  • 4 °C, -20°C if preferred

Target

  • Alternative Names
  • CLDN6; claudin 6; claudin-6; skullin
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-160CL. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# AFC-160CL, RRID: AB_3111277)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "CLDN6"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
VS-0425-YC130 Recombinant Anti-CLDN6 Vesicular Antibody, EV Displayed (VS-0425-YC130) Cyt, ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare